BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30589872)

  • 1. A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn's disease patients.
    Li Yim AYF; de Bruyn JR; Duijvis NW; Sharp C; Ferrero E; de Jonge WJ; Wildenberg ME; Mannens MMAM; Buskens CJ; D'Haens GR; Henneman P; Te Velde AA
    PLoS One; 2018; 13(12):e0209656. PubMed ID: 30589872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of DNA methylation and gene expression defines molecular characteristics of Crohn's disease-associated fibrosis.
    Sadler T; Bhasin JM; Xu Y; Barnholz-Sloan J; Chen Y; Ting AH; Stylianou E
    Clin Epigenetics; 2016; 8():30. PubMed ID: 26973718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered microRNA expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn's disease.
    Guo Z; Wu R; Gong J; Zhu W; Li Y; Wang Z; Li N; Li J
    J Gastroenterol Hepatol; 2015 Jan; 30(1):109-16. PubMed ID: 24910152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ileal Derived Organoids From Crohn's Disease Patients Show Unique Transcriptomic and Secretomic Signatures.
    Niklinska-Schirtz BJ; Venkateswaran S; Anbazhagan M; Kolachala VL; Prince J; Dodd A; Chinnadurai R; Gibson G; Denson LA; Cutler DJ; Jegga AG; Matthews JD; Kugathasan S
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1267-1280. PubMed ID: 34271224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-seq Reveals Transcriptomic Differences in Inflamed and Noninflamed Intestinal Mucosa of Crohn's Disease Patients Compared with Normal Mucosa of Healthy Controls.
    Hong SN; Joung JG; Bae JS; Lee CS; Koo JS; Park SJ; Im JP; Kim YS; Kim JW; Park WY; Kim YH
    Inflamm Bowel Dis; 2017 Jul; 23(7):1098-1108. PubMed ID: 28613228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose stem cells from patients with Crohn's disease show a distinctive DNA methylation pattern.
    Serena C; Millan M; Ejarque M; Saera-Vila A; Maymó-Masip E; Núñez-Roa C; Monfort-Ferré D; Terrón-Puig M; Bautista M; Menacho M; Martí M; Espin E; Vendrell J; Fernández-Veledo S
    Clin Epigenetics; 2020 Apr; 12(1):53. PubMed ID: 32252817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation.
    Somineni HK; Venkateswaran S; Kilaru V; Marigorta UM; Mo A; Okou DT; Kellermayer R; Mondal K; Cobb D; Walters TD; Griffiths A; Noe JD; Crandall WV; Rosh JR; Mack DR; Heyman MB; Baker SS; Stephens MC; Baldassano RN; Markowitz JF; Dubinsky MC; Cho J; Hyams JS; Denson LA; Gibson G; Cutler DJ; Conneely KN; Smith AK; Kugathasan S
    Gastroenterology; 2019 Jun; 156(8):2254-2265.e3. PubMed ID: 30779925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Implications of MicroRNAs in Crohn's Disease Revealed by Integrating MicroRNA and Messenger RNA Expression Profiling.
    Palmieri O; Creanza TM; Bossa F; Latiano T; Corritore G; Palumbo O; Martino G; Biscaglia G; Scimeca D; Carella M; Ancona N; Andriulli A; Latiano A
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiles of mucosal fibroblasts from strictured and nonstrictured areas of patients with Crohn's disease.
    Lang M; Schlechtweg M; Kellermeier S; Brenmoehl J; Falk W; Schölmerich J; Herfarth H; Rogler G; Hausmann M
    Inflamm Bowel Dis; 2009 Feb; 15(2):212-23. PubMed ID: 18839425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy.
    Stankovic B; Dragasevic S; Klaassen K; Kotur N; Srzentic Drazilov S; Zukic B; Sokic Milutinovic A; Milovanovic T; Lukic S; Popovic D; Pavlovic S; Nikcevic G
    Pathol Res Pract; 2020 Jun; 216(6):152945. PubMed ID: 32279918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis.
    Vasquez N; Mangin I; Lepage P; Seksik P; Duong JP; Blum S; Schiffrin E; Suau A; Allez M; Vernier G; Tréton X; Doré J; Marteau P; Pochart P
    Inflamm Bowel Dis; 2007 Jun; 13(6):684-92. PubMed ID: 17206669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered gut transcriptome in spondyloarthropathy.
    Laukens D; Peeters H; Cruyssen BV; Boonefaes T; Elewaut D; De Keyser F; Mielants H; Cuvelier C; Veys EM; Knecht K; Van Hummelen P; Remaut E; Steidler L; De Vos M; Rottiers P
    Ann Rheum Dis; 2006 Oct; 65(10):1293-300. PubMed ID: 16476712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal mucosa-derived DNA methylation signatures in the penetrating intestinal mucosal lesions of Crohn's disease.
    Li Y; Wang Z; Wu X; Wang G; Gu G; Ren H; Hong Z; Ren J
    Sci Rep; 2021 May; 11(1):9771. PubMed ID: 33963246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Methylation Profiling in 229 Patients With Crohn's Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn's Disease (TOPPIC).
    Ventham NT; Kennedy NA; Kalla R; Adams AT; Noble A; Ennis H; ; ; Mowat C; Dunlop MG; Satsangi J
    Cell Mol Gastroenterol Hepatol; 2023; 16(3):431-450. PubMed ID: 37331566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth Muscle Hyperplasia/Hypertrophy is the Most Prominent Histological Change in Crohn's Fibrostenosing Bowel Strictures: A Semiquantitative Analysis by Using a Novel Histological Grading Scheme.
    Chen W; Lu C; Hirota C; Iacucci M; Ghosh S; Gui X
    J Crohns Colitis; 2017 Jan; 11(1):92-104. PubMed ID: 27364949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrostenotic Phenotype of Myofibroblasts in Crohn's Disease is Dependent on Tissue Stiffness and Reversed by LOX Inhibition.
    de Bruyn JR; van den Brink GR; Steenkamer J; Buskens CJ; Bemelman WA; Meisner S; Muncan V; Te Velde AA; D'Haens GR; Wildenberg ME
    J Crohns Colitis; 2018 Jun; 12(7):849-859. PubMed ID: 29672662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does active Crohn's disease have decreased intestinal antioxidant capacity?
    Pinto MA; Lopes MS; Bastos ST; Reigada CL; Dantas RF; Neto JC; Luna AS; Madi K; Nunes T; Zaltman C
    J Crohns Colitis; 2013 Oct; 7(9):e358-66. PubMed ID: 23523266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease.
    VanDussen KL; Stojmirović A; Li K; Liu TC; Kimes PK; Muegge BD; Simpson KF; Ciorba MA; Perrigoue JG; Friedman JR; Towne JE; Head RD; Stappenbeck TS
    Gastroenterology; 2018 Sep; 155(3):815-828. PubMed ID: 29782846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease.
    Söderholm JD; Olaison G; Peterson KH; Franzén LE; Lindmark T; Wirén M; Tagesson C; Sjödahl R
    Gut; 2002 Mar; 50(3):307-13. PubMed ID: 11839706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.